Brexpiprazole

Rexulti

Atypical Antipsychotic

NADAC/unit $49.5026

No Shortage Tier 1: 107.6% PA Req: 228.0% 1 Manufacturers 6 ANDAs

Brexpiprazole treats schizophrenia, bipolar disorder, and related conditions by modulating dopamine and serotonin receptors.

vs. brand Rexulti: Generic saves up to -395% per unit

Covered Lives

Generic Manufacturers

ALEMBIC PHARMACEUTICALS LTDOTSUKA PHARMACEUTICAL CO LTD

Explore in the Ecosystem

rxsaver.aiCompare prices for Brexpiprazole drfinder.aiFind doctors who prescribe Brexpiprazole rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Brexpiprazole

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.